Pfizer Recalls Greenstone Fluconazole Oral Suspension Due to Tamper Ring Failures
Pfizer is recalling 4,155 bottles of Greenstone brand fluconazole oral suspension because some bottles have defective tamper-evident rings.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a packaging defect (tamper-evident ring failure) without reported injuries or illnesses, fitting the criteria for a moderate severity recall.
Plain-English summary
Pfizer Inc. is recalling 4,155 bottles of Greenstone brand fluconazole for Oral Suspension, Orange Flavored, 40 mg/mL. The product is a prescription-only medication distributed by Greenstone LLC in Peapack, New Jersey, and manufactured in India. The specific lot affected is # A358502 with an expiration date of 01/15.
The recall was initiated because defective tamper-evident ring failures were discovered on some of the bottles. This defect compromises the integrity of the container's tamper-evident feature. The affected product was distributed nationwide, as well as in Italy and the Republic of South Korea.
Consumers and healthcare providers who have this specific lot of fluconazole oral suspension should stop using it and contact their pharmacist or healthcare provider for instructions on how to return the product or obtain a replacement.
The recalled product
- Product
- FLUCONAZOLE (FLUCONAZOLE)
- Brand
- FLUCONAZOLE
- Manufacturer
- Pfizer Inc.
- Category
- Drug — Antifungal
- Affected units
- 4,155
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # A358502
- Exp 01/15
UPCs (3)
- 0359762503015
- 0359762501516
- 0359762502919
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · FLUCONAZOLE
- SevereBaxter Recalls Fluconazole Injection Bags Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- ModerateFluconazole Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2017-05-10
- ModerateHarvard Drug Group Recalls Fluconazole Tablets for Failed Dissolution
FDA (Drugs) · 2017-05-10
- ModerateDr. Reddy's Recalls Flucanazole Tablets Due to Dissolution Failures
FDA (Drugs) · 2017-02-08
- HighDr. Reddy's Recalls Flucanazole Tablets for Dissolution Failures
FDA (Drugs) · 2017-02-08
Same manufacturer · Pfizer Inc.
See all →- HighSodium bicarbonate injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighEpinephrine injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighBicillin L-A 2.4 million unit vials recalled after particulates found
FDA (Drugs) · 2025-08-06
- HighBicillin L-A penicillin vials recalled after particulates found during visual inspection
FDA (Drugs) · 2025-08-06
- ModerateDobutamine Injection Recall Due to Discoloration and Cracked Vials
FDA (Drugs) · 2025-07-02
Same hazard · packaging defect
See all →- HighMD Wipe Outz Numbing Tattoo Wipes Recalled for Child Poisoning Risk
CPSC · 2026-08-27
- HighV-Loc 90 Absorbable Wound Closure Devices Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- SevereDermalon Sutures Recalled for Potential Sterile Barrier Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 180 Absorbable Wound Closure Device Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighBiopsy Forceps Recall: Sterile Packaging Breach Risk
FDA (Devices) · 2026-08-12